Pharmaceutical

IBA venture PanTera gains €134m in funding to scale up actinium-225 production

The IBA-SCK CEN joint venture secured funds to increase production of the radioisotope used in cancer therapies.

Sep 12, 2024 - 04:00
IBA venture PanTera gains €134m in funding to scale up actinium-225 production
The IBA-SCK CEN joint venture secured funds to increase production of the radioisotope used in cancer therapies.
Read the original article

Tags:

Previous Article

EASD 2024: Are tetra-agonists the future of metabolic diseases treatment?

Next Article

EASD 2024: Novo Nordisk’s Saxenda shows weight loss in children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Social media algorithms are driving the GLP-1 drugs boom

Social media algorithms are driving the GLP-1 drugs boom

Oct 4, 2024

Sanofi completes the $1.7bn acquisition of Inhibrx

Sanofi completes the $1.7bn acquisition of Inhibrx

May 31, 2024

WestGene wins FDA nod to study mRNA vaccine to treat certain cancers

WestGene wins FDA nod to study mRNA vaccine to treat ce...

May 11, 2024